JOP Publishes Clinical Pathways and Patient Safety Studies From Quality Care Symposium
The Journal of Oncology Practice (JOP) published three articles online in conjunction with the oral presentations of the data during ASCO’s 2017 Quality Care Symposium in Orlando. “The research presented at ASCO’s Quality Care Symposium enhances our understanding of a wide variety of methods to measure and improve cancer care,” said John V. Cox, DO, MBA, FACP, and Editor-in-Chief of JOP.
The abstracts include:
- Abstract 3: Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non–Small Cell Lung Cancer, presented by Yichen Zhang, PhD, of Dana-Farber Cancer Institute (available at http://ascopubs.org/doi/abs/10.1200/JOP.2017.021741)
- Abstract 37: Significant and Sustained Reduction in Chemotherapy Errors Through Improvement Science, presented by Brian D. Weiss, MD, of Cincinnati Children’s Hospital Medical Center (available at http://ascopubs.org/doi/abs/10.1200/JOP.2017.020842)
- Abstract 52: Reducing Overuse of Colony-Stimulating Factors Without Compromising Patient Safety: Evidence From a Decision-Support Enabled Utilization Management Program in Patients With Lung Cancer Receiving Chemotherapy, presented by Gboyega Adeboveje, MD, MS, of HealthCore, Inc (available at http://ascopubs.org/doi/abs/10.1200/JOP.2017.020867). ■